Madurella mycetomatis is highly susceptible to ravuconazole.

• Auteurs principaux: Sarah Abdalla Ahmed (Auteur), Wendy Kloezen (Auteur), Frederick Duncanson (Auteur), Ed E Zijlstra (Auteur), G Sybren de Hoog (Auteur), Ahmed H Fahal (Auteur), Wendy W J van de Sande (Auteur)
• Format: Livre
• Publié: Public Library of Science (PLoS), 2014-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

The current treatment of eumycetoma utilizing ketoconazole is unsatisfactory because of high recurrence rates, which often leads to complications and unnecessary amputations, and its comparatively high cost in endemic areas. Hence, an effective and affordable drug is required to improve therapeutic...